Carl W. Baker

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA · 2015 · 762 citations

Medicine, Ophthalmology, Pharmacotherapy +14

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

Jeffrey G. Gross, Adam R. Glassman, Danni Liu et al. · JAMA Ophthalmology · 2018 · 387 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity

Carl W. Baker, Adam R. Glassman, Wesley T. Beaulieu et al. · JAMA · 2019 · 295 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Progression of Geographic Atrophy in Age-related Macular Degeneration

Tiarnán D L Keenan, Elvira Agrón, Amitha Domalpally et al. · Ophthalmology · 2018 · 211 citations

Medicine, Ophthalmology, Vision Science +14

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

Adam R. Glassman, John A. Wells, Kristin Josic et al. · Ophthalmology · 2020 · 198 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +10